North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030By Press Room27 January 2024 North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement…